A Case of Bilateral Irreversible Loss of Vision in a Young Child Due to Mumps Retinitis | Canada Hyperbarics Skip to main content
Case Report Ocul Immunol Inflamm 2025

A Case of Bilateral Irreversible Loss of Vision in a Young Child Due to Mumps Retinitis

Wani V, Mutalik D, Mahendradas P, Patil M — Ocul Immunol Inflamm, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers documented the case of a five-year-old boy who experienced severe and permanent vision loss in both eyes after developing mumps.

What They Found

A five-year-old boy presented with bilateral blindness, having only perception of light, two days after experiencing fever and parotid swelling. His examination revealed extensive eye damage, including outer retinal necrosis and retinal detachment in both eyes. Despite receiving various treatments, including intravenous methylprednisolone, oral valganciclovir, hyperbaric oxygen, and plasmapheresis, his vision did not improve and remained at only perception of light.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a case report, this study describes the unique experience of only one patient and its findings cannot be generalized to a larger population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 40047036
Year Published 2025
Journal Ocul Immunol Inflamm
MeSH Terms Humans; Male; Tomography, Optical Coherence; Mumps; Eye Infections, Viral; Child, Preschool; Retinitis; Visual Acuity; Fluorescein Angiography; Blindness; Mumps virus; Antibodies, Viral; Fundus Oculi

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology